BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2967756)

  • 1. Neurochemistry of dementia.
    Whitehouse PJ; Unnerstall JR
    Eur Neurol; 1988; 28 Suppl 1():36-41. PubMed ID: 2967756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral metabolic relationships for selected brain regions in Alzheimer's, Huntington's, and Parkinson's diseases.
    Metter EJ; Riege WH; Kameyama M; Kuhl DE; Phelps ME
    J Cereb Blood Flow Metab; 1984 Dec; 4(4):500-6. PubMed ID: 6238975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptides in neurological disease.
    Beal MF; Martin JB
    Ann Neurol; 1986 Nov; 20(5):547-65. PubMed ID: 2947536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is "subcortical dementia" a recognizable clinical entity?
    Mayeux R; Stern Y; Rosen J; Benson F
    Ann Neurol; 1983 Sep; 14(3):278-83. PubMed ID: 6227275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemical anatomy of movement disorders.
    Young AB; Penney JB
    Neurol Clin; 1984 Aug; 2(3):417-33. PubMed ID: 6152481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurochemistry of dementia: establishing the links.
    Whitehouse PJ; Gambetti P; Harik SI; Kalaria RN; Perry G; Younkin SI; Tabaton M; Unnerstall JR
    Prog Clin Biol Res; 1989; 317():131-42. PubMed ID: 2574868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation].
    Dubois B; Hauw JJ; Ruberg M; Serdaru M; Javoy-Agid F; Agid Y
    Rev Neurol (Paris); 1985; 141(3):184-93. PubMed ID: 4001706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical muscarinic receptors in demented patients with Alzheimer's disease or Parkinson's disease.
    Lange KW; Wells FR; Rossor MN; Jenner P; Marsden CD
    Br J Pharmacol; 1989 Dec; 98 Suppl():817P. PubMed ID: 2611524
    [No Abstract]   [Full Text] [Related]  

  • 9. Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method.
    Kuhl DE; Metter EJ; Riege WH
    Ann Neurol; 1984 May; 15(5):419-24. PubMed ID: 6610384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The concept of subcortical and cortical dementia: another look.
    Whitehouse PJ
    Ann Neurol; 1986 Jan; 19(1):1-6. PubMed ID: 2868689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
    Sian J; Dexter DT; Lees AJ; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden CD
    Ann Neurol; 1994 Sep; 36(3):348-55. PubMed ID: 8080242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotransmitters and neurodegenerative disorders.
    Kanazawa I
    Clin Ther; 1984; 7 Spec No():48-58. PubMed ID: 6152198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of excitotoxins in heredito-degenerative neurologic diseases.
    Young AB
    Res Publ Assoc Res Nerv Ment Dis; 1993; 71():175-89. PubMed ID: 8093331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A review on neurotransmitter in clinical neurology (author's transl)].
    Kanazawa I
    No To Shinkei; 1977 Dec; 29(12):1245-60. PubMed ID: 74257
    [No Abstract]   [Full Text] [Related]  

  • 16. Animal models of Alzheimer's Parkinson's and Huntington's disease. A minireview.
    Antal A; Bodis-Wollner I
    Neurobiology (Bp); 1993; 1(2):101-22. PubMed ID: 8111350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyzing the subcortical dementia syndrome of Parkinson's disease using the RBANS.
    Beatty WW; Ryder KA; Gontkovsky ST; Scott JG; McSwan KL; Bharucha KJ
    Arch Clin Neuropsychol; 2003 Jul; 18(5):509-20. PubMed ID: 14591446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease-related protein changes in purified neurons from Alzheimer's and Huntington's diseases.
    Selkoe DJ
    Trans Am Neurol Assoc; 1979; 104():70-4. PubMed ID: 162259
    [No Abstract]   [Full Text] [Related]  

  • 20. Deposition of amyloid (A4) protein within the brains of persons with dementing disorders other than Alzheimer's disease and Down's syndrome.
    Mann DM; Jones D
    Neurosci Lett; 1990 Feb; 109(1-2):68-75. PubMed ID: 2138261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.